Effect of remifentanil on pre-osteoclast cell differentiation in vitro |
Jeon, Hyun-Ook
(Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute)
Choi, In-Seok (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute) Yoon, Ji-Young (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute) Kim, Eun-Jung (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute) Yoon, Ji-Uk (Department of Anesthesia and Pain Medicine, School of Medicine, Pusan National University) Cho, Ah-Reum (Department of Anesthesia and Pain Medicine, Pusan National University Hospital) Kim, Hyung-Joon (Department of Oral Physiology, School of Dentistry, Pusan National University) Kim, Cheul-Hong (Department of Dental Anesthesia and Pain Medicine, School of Dentistry, Pusan National University, Dental Research Institute) |
1 | Hadjidakis DJ, Androulakis II. Bone remodeling. Ann N Y Acad Sci 2006; 1092: 385-96. DOI |
2 | Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-8. DOI |
3 | Roodman GD. Advances in bone biology: The osteoclast. Endocr Rev 1996; 17: 308-32. |
4 | Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93: 165-76. DOI |
5 | Teitelbaum SL, Ross FP. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003; 4: 638-49. DOI |
6 | Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J Exp Med 2005; 202: 337-40. DOI |
7 | Vignery A. Osteoclasts and giant cells: macrophagemacrophage fusion mechanism. Int J Exp Pathol 2000; 81: 291-304. DOI |
8 | Glass PS, Gan TJ, Howell S. a review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg 1999; 89: S7-14. |
9 | Scott LJ, Perry CM. Remifentanil: A review of its use during the induction and maintenance of general anaesthesia. Drugs 2005; 65: 1793-823. DOI |
10 |
Yoon JY, Kim DW, Kim EJ, Park BS, Yoon JU, Kim HJ, et al. Protective effects of remifentanil against |
11 | Baik SW, Park BS, Kim YH, Kim YD, Kim CH, Yoon JY, et al. Effects of remifentanil preconditioning on osteoblasts under hypoxia-reoxygenation condition. Int J Med Sci 2015; 12: 583-9. DOI |
12 | Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002; 3: 889-901. DOI |
13 | Ha J, Choi HS, Lee Y, Lee ZH, Kim HH. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Int Immunopharmacol 2009; 9: 774-80. DOI |
14 | Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997; 15: 707-47. DOI |
15 | Chen EH, Grote E, Mohler W, Vignery A. Cell-cell fusion. FEBS Lett 2007; 581: 2181-93. DOI |
16 | Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med (Berl) 2005; 83: 170-9. DOI |
17 | Yagi M, Ninomiya K, Fujita N, Suzuki T, Iwasaki R, Morita K, et al. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms. J Bone Miner Res 2007; 22: 992-1001. DOI |
18 | Felix R, Hofstetter W, Wetterwald A, Cecchini MG, Fleisch H. Role of colony-stimulating factor-1 in bone metabolism. J Cell Biochem 1994; 55: 340-9. DOI |
19 | Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, et al. c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 1994; 266: 443-8. DOI |
20 | Kular J, Tickner J, Chim SM, Xu J. An overview of the regulation of bone remodelling at the cellular level. Clin Biochem 2012; 45: 863-73. DOI |
21 | Ishii M, Saeki Y. Osteoclast cell fusion: mechanisms and molecules. Mod Rheumatol 2008; 18: 220-7. DOI |
22 | Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem 2010; 285: 25103-8. DOI |
23 | Corral DA, Amling M, Priemel M, Loyer E, Fuchs S, Ducy P, et al. Dissociation between bone resorption and bone formation in osteopenic transgenic mice. Proc Natl Acad Sci U S A 1998; 95: 13835-40. DOI |
24 | Hou GQ, Guo C, Song GH, Fang N, Fan WJ, Chen XD, et al. Lipopolysaccharide (LPS) promotes osteoclast differentiation and activation by enhancing the MAPK pathway and COX-2 expression in RAW264.7 cells. Int J Mol Med 2013; 32: 503-10. DOI |
25 | Zou W, Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 2002; 17: 1211-8. DOI |
26 | Chambers TJ. Regulation of the differentiation and function of osteoclasts. J Pathol 2000; 192: 4-13. DOI |
27 | Hauge EM, Qvesel D, Eriksen EF, Mosekilde L, Melsen F. Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res 2001; 16: 1575-82. DOI |
![]() |